Latanoprost and cholinergic agonists in combination

Survey of Ophthalmology

Volumn 47, Issue 4 SUPPL. 1, 2002, Pages

  Toris, Carol B ^a,c   Alm, Albert ^b   Camras, Carl B ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c 985540 Nebraska Medical Center ^*  (United States)

Author keywords

Additivity; Glaucoma; Human; Intraocular pressure; Latanoprost; Ocular hypertension; Outflow facility; Pilocarpine; Review; Uveoscleral outflow

Indexed keywords

CHOLINERGIC RECEPTOR STIMULATING AGENT; LATANOPROST; MIOTIC AGENT; PHYSOSTIGMINE; PILOCARPINE; PROSTAGLANDIN F2 ALPHA;

AQUEOUS HUMOR FLOW; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG TOLERABILITY; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; NONHUMAN; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

ANTIHYPERTENSIVE AGENTS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MUSCARINIC AGONISTS; OCULAR HYPERTENSION; PILOCARPINE; PROSTAGLANDINS F, SYNTHETIC;

EID: 0036669304     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6257(02)00309-0     Document Type: Review

References (25)

1. Alm A., Widengård I., Kjellgren D.et al. Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol. Br J Ophthalmol. 79:1995;12-16.
2. Bill A. Effects of atropine and pilocarpine on aqueous humour dynamics in cynomolgus monkeys (Macaca irus). Exp Eye Res. 6:1967;120-125.
3. Bill A., Wålinder P.-E. The effects of pilocarpine on the dynamics of aqueous humor in a primate (Macaca irus). Invest Ophthalmol. 5:1966;170-175.
4. 2α on IOP in glaucomatous monkey eyes. Invest Ophthalmol Vis Sci. 31(Suppl):1990;150. [abstract].
5. 2α. Arch Ophthalmol. 105:1987;1112-1116.
6. Friström B., Nilsson S.E.G. Interaction of PhXA41, a new prostaglandin analogue, with pilocarpine. A study on patients with elevated intraocular pressure. Arch Ophthalmol. 111:1993;662-665.
7. 2α increases uveoscleral outflow in the cynomolgus monkey. Exp Eye Res. 49:1989;389-402.
8. Kent A.R., Vroman D.T., Thomas T.J.et al. Interaction of pilocarpine with latanoprost in patients with glaucoma and ocular hypertension. J Glaucoma. 8:1999;257-262.
9. Lindén C., Alm A. Latanoprost and physostigmine have mostly additive ocular hypotensive effects in human eyes. Arch Ophthalmol. 115:1997;857-861.
10. Lindén C., Alm A. Latanoprost twice daily is less effective than once daily. indication of receptor subsensitivity? Curr Eye Res. 17:1998;567-572.
11. Lindsey J.D., Kashiwagi K., Kashiwagi F., Weinreb R.N. Prostaglandin action on ciliary smooth muscle extracellular matrix metabolism: Implications for uveoscleral outflow Surv Ophthalmol. 41(Suppl):1997;S53-S59.
12. Lindsey J.D., Kashiwagi K., Kashiwagi F., Weinreb R.N. Prostaglandins alter extracellular matrix adjacent to human ciliary muscle cells in vitro. Invest Ophthalmol Vis Sci. 38:1997;2214-2223.
13. 2α Exp Eye Res. 47:1988;761-769.
14. Mishima H.K., Kiuchi Y., Takamatsu M.et al. Circadian intraocular pressure management with latanoprost. diurnal and nocturnal intraocular pressure reduction and increased uveoscleral outflow Surv Ophthalmol. 41(Suppl):1997;S139-S144.
15. Nagasubramanian S., Sheth G.P., Hitchings R.A., Stjernschantz J. Intraocular pressure-reducing effect of PhXA41 in ocular hypertension. Comparison of dose regimens. Ophthalmology. 100:1993;1305-1311.
16. 2α-1-isopropylester in the cynomolgus monkey. Exp Eye Res. 48:1989;707-716.
17. Patelska B., Greenfield D.S., Liebmann J.M.et al. Latanoprost for uncontrolled glaucoma in a compassionate case protocol. Am J Ophthalmol. 124:1997;279-286.
18. 2α effects on isolated rhesus monkey ciliary muscle. Invest Ophthalmol Vis Sci. 36:1995;2461-2465.
19. Shin D.H., McCracken M.S., Bendel R.E.et al. The additive effect of latanoprost to maximum-tolerated medications with low-dose, high-dose and no pilocarpine therapy. Ophthalmology. 106:1999;386-390.
20. 2α analogue. Samuelsson B., Ramwell P.W., Paoletti R.et al. Advances in Prostaglandin, Thromboxane, and Leukotriene Research. 1995;513-518 Raven Press, Ltd, New York.
21. 2α analog, on aqueous humor dynamics in human eyes. Ophthalmology. 100:1993;1297-1304.
22. Toris C.B., Camras C.B., Yablonski M.E., Brubaker R.F. Effects of exogenous prostaglandins on aqueous humor dynamics and blood-aqueous barrier function. Surv Ophthalmol. 41(Suppl):1997;S69-S75.
23. Toris C.B., Zhan G.-L., Zhao J.et al. Potential mechanism for the additivity of pilocarpine and latanoprost. Am J Ophthalmol. 131:2001;722-728.
24. Van Alphen G.W.H.M., Wilhelm P.B., Elsenfeld P.W. The effect of prostaglandins on the isolated internal muscles of the mammalian eye, including man. Doc Ophthalmol. 42:1977;397-415.
25. Weinreb R.N., Toris C.B., Gabelt B.T.et al. Effects of prostaglandins on the aqueous humor outflow pathways. Surv Ophthalmol. 47(Suppl 1):2002;S53-S64.